Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Galmed Pharmaceuticals - 11 Year Stock Price History | GLMD

Historical daily share price chart and data for Galmed Pharmaceuticals since 2014 adjusted for splits and dividends. The latest closing stock price for Galmed Pharmaceuticals as of July 18, 2025 is 1.83.
  • The all-time high Galmed Pharmaceuticals stock closing price was 3232.80 on June 13, 2018.
  • The Galmed Pharmaceuticals 52-week high stock price is 23.80, which is 1200.5% above the current share price.
  • The Galmed Pharmaceuticals 52-week low stock price is 1.15, which is 37.2% below the current share price.
  • The average Galmed Pharmaceuticals stock price for the last 52 weeks is 2.85.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Galmed Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 1.9605 3.3200 3.4300 1.1900 1.8300 -42.63%
2024 4.1562 5.2764 15.1000 2.5600 3.1900 -41.58%
2023 44.5676 128.0340 162.0000 3.5316 5.4600 -93.93%
2022 149.0985 372.6000 372.6000 52.2000 90.0000 -72.53%
2021 551.1856 574.2000 972.0000 315.0000 327.6000 -41.48%
2020 807.5099 1044.0000 1231.2000 550.8000 559.8000 -46.19%
2019 1147.2871 1368.0000 1632.6000 649.8000 1040.4000 -15.37%
2018 1749.0065 1690.2000 3232.8000 907.2000 1229.4000 -25.36%
2017 1151.6585 653.4000 1677.6000 653.4000 1647.0000 160.68%
2016 833.8634 1359.0000 1377.0000 513.0000 631.8000 -53.88%
2015 1621.4723 1049.4000 2385.0000 1049.4000 1369.8000 31.21%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.004B $0.000B
Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company. It is focused on developing therapies for liver diseases and gallstones. Galmed Pharmaceuticals Ltd. is based in Tel Aviv, Israel.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $76.846B 28.83
Zoetis (ZTS) United States $66.795B 24.92
Takeda Pharmaceutical (TAK) Japan $46.902B 9.33
Daiichi Sankyo, - (DSNKY) Japan $45.540B 23.34
BeOne Medicines - (ONC) Cayman Islands $31.822B 0.00
Sandoz Group AG (SDZNY) Switzerland $24.640B 0.00
Summit Therapeutics (SMMT) United States $20.520B 0.00
Merck (MKKGY) Germany $16.743B 12.27
Shionogi (SGIOY) Japan $14.360B 14.39
United Therapeutics (UTHR) United States $13.412B 11.86
Neurocrine Biosciences (NBIX) United States $13.272B 45.46
Orion OYJ (ORINY) Finland $10.973B 29.68
IPSEN (IPSEY) France $10.477B 0.00
Corcept Therapeutics (CORT) United States $7.752B 63.02
Madrigal Pharmaceuticals (MDGL) United States $7.743B 0.00
Stevanato Group S.p.A (STVN) Italy $7.719B 47.20
Grifols, S.A (GRFS) Spain $6.910B 0.00
Ionis Pharmaceuticals (IONS) United States $6.712B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.417B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.092B 0.00
Hypermarcas (HYPMY) Brazil $2.939B 19.33
Catalyst Pharmaceuticals (CPRX) United States $2.616B 9.17
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.583B 13.97
NewAmsterdam Pharma (NAMS) Netherlands $2.468B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.132B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.820B 0.00
Ocular Therapeutix (OCUL) United States $1.813B 0.00
ARS Pharmaceuticals (SPRY) United States $1.802B 0.00
Endo (NDOI) United States $1.622B 0.00
Evotec AG (EVO) Germany $1.506B 0.00
Harrow (HROW) United States $1.326B 0.00
Guardian Pharmacy Services (GRDN) United States $1.317B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.225B 24.51
Enliven Therapeutics (ELVN) United States $1.145B 0.00
Ardelyx (ARDX) United States $1.081B 0.00
Dyne Therapeutics (DYN) United States $1.068B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.049B 0.00
Collegium Pharmaceutical (COLL) United States $1.037B 5.59
ProKidney (PROK) United States $1.030B 0.00
Akebia Therapeutics (AKBA) United States $1.019B 0.00
Verve Therapeutics (VERV) United States $0.976B 0.00
Xeris Biopharma Holdings (XERS) United States $0.818B 0.00
KalVista Pharmaceuticals (KALV) United States $0.800B 0.00
Cronos Group (CRON) Canada $0.791B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.738B 0.00
Zevra Therapeutics (ZVRA) United States $0.692B 0.00
Xencor (XNCR) United States $0.646B 0.00
Relay Therapeutics (RLAY) United States $0.626B 0.00
Elite Pharmaceuticals (ELTP) United States $0.609B 0.00
Theravance Biopharma (TBPH) United States $0.581B 0.00
Oruka Therapeutics (ORKA) United States $0.575B 0.00
USANA Health Sciences (USNA) United States $0.570B 12.40
Organogenesis (ORGO) United States $0.553B 0.00
Bioventus (BVS) United States $0.533B 13.52
Siga Technologies (SIGA) United States $0.479B 10.00
Tourmaline Bio (TRML) United States $0.478B 0.00
Aquestive Therapeutics (AQST) United States $0.434B 0.00
Savara (SVRA) United States $0.404B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.347B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.338B 9.14
Nektar Therapeutics (NKTR) United States $0.331B 0.00
Altimmune (ALT) United States $0.328B 0.00
Heron Therapeutics (HRTX) United States $0.305B 0.00
AleAnna (ANNA) United States $0.301B 0.00
Aldeyra Therapeutics (ALDX) United States $0.301B 0.00
Nature's Sunshine Products (NATR) United States $0.271B 24.88
Nanobiotix S.A (NBTX) France $0.250B 0.00
Esperion Therapeutics (ESPR) United States $0.246B 0.00
OmniAb (OABI) United States $0.239B 0.00
MediWound (MDWD) Israel $0.217B 0.00
Larimar Therapeutics (LRMR) United States $0.213B 0.00
4D Molecular Therapeutics (FDMT) United States $0.202B 0.00
China SXT Pharmaceuticals (SXTC) China $0.196B 0.00
Galectin Therapeutics (GALT) United States $0.183B 0.00
Aclaris Therapeutics (ACRS) United States $0.172B 0.00
Profound Medical (PROF) Canada $0.171B 0.00
Journey Medical (DERM) United States $0.170B 0.00
Avita Medical (RCEL) United States $0.144B 0.00
Liminatus Pharma (LIMN) United States $0.142B 0.00
Lexeo Therapeutics (LXEO) United States $0.141B 0.00
Inhibikase Therapeutics (IKT) United States $0.141B 0.00
Lyell Immunopharma (LYEL) United States $0.141B 0.00
Korro Bio (KRRO) United States $0.130B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.128B 0.00
Protara Therapeutics (TARA) United States $0.121B 0.00
Champions Oncology (CSBR) United States $0.116B 19.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.104B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
Cardiol Therapeutics (CRDL) Canada $0.098B 0.00
Achieve Life Sciences (ACHV) Canada $0.095B 0.00
Vivani Medical (VANI) United States $0.094B 0.00
VAXART, INC (VXRT) United States $0.093B 0.00
Fractyl Health (GUTS) United States $0.088B 0.00
Nutriband (NTRB) United States $0.087B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Dominari Holdings (DOMH) United States $0.082B 0.00
Context Therapeutics (CNTX) United States $0.082B 0.00
Rafael Holdings (RFL) United States $0.080B 0.00
Metagenomi (MGX) United States $0.080B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.079B 0.00
Surrozen (SRZN) United States $0.073B 0.00
Pyxis Oncology (PYXS) United States $0.072B 0.00
PMV Pharmaceuticals (PMVP) United States $0.069B 0.00
Wellgistics Health (WGRX) United States $0.066B 0.00
Assertio Holdings (ASRT) United States $0.064B 0.00
Klotho Neurosciences (KLTO) United States $0.063B 0.00
Avalo Therapeutics (AVTX) United States $0.061B 0.00
Inotiv (NOTV) United States $0.061B 0.00
Unicycive Therapeutics (UNCY) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Jupiter Neurosciences (JUNS) United States $0.057B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.056B 41.22
ElectroCore (ECOR) United States $0.055B 0.00
NRx Pharmaceuticals (NRXP) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.050B 0.00
Gain Therapeutics (GANX) United States $0.048B 0.00
Prelude Therapeutics (PRLD) United States $0.046B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.041B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
PolyPid (PYPD) Israel $0.039B 0.00
Telomir Pharmaceuticals (TELO) United States $0.036B 0.00
Karyopharm Therapeutics (KPTI) United States $0.035B 0.00
Vivos Therapeutics (VVOS) United States $0.034B 0.00
FibroGen (FGEN) United States $0.033B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
Scienture Holdings (SCNX) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.022B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
BioLineRx (BLRX) Israel $0.020B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Plus Therapeutics (PSTV) United States $0.020B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.019B 0.00
VYNE Therapeutics (VYNE) United States $0.018B 0.00
Citius Pharmaceuticals (CTXR) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
DURECT (DRRX) United States $0.016B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
ProPhase Labs (PRPH) United States $0.016B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
BioVie (BIVI) United States $0.015B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Minerva Neurosciences (NERV) United States $0.014B 2.43
TherapeuticsMD (TXMD) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Ainos (AIMD) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Incannex Healthcare (IXHL) Australia $0.011B 0.00
Aptorum Group (APM) United Kingdom $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Redhill Biopharma (RDHL) Israel $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.45
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00